Cargando…

PI-8 Vaccine induced and naturally acquired antibodies against mumps virus

Detalles Bibliográficos
Autores principales:	Broman, M., Jokinen, S., Davidkin, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2009
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128418/ http://dx.doi.org/10.1016/S1386-6532(09)70088-5

Ejemplares similares

Improved Immunogenicity of the Inactivated F Genotype Mumps Vaccine against Diverse Circulating Mumps Viruses in Mice
por: Won, Hyeran, et al.
Publicado: (2023)

A New Method for the Detection of Neutralizing Antibodies against Mumps Virus
por: Matsubara, Keita, et al.
Publicado: (2013)

Mumps Vaccine Effectiveness Against Orchitis
por: Hahné, Susan, et al.
Publicado: (2012)

IMMUNITY IN MUMPS : VI. EXPERIMENTS ON THE VACCINATION OF HUMAN BEINGS WITH FORMOLIZED MUMPS VIRUS
por: Stokes, Joseph, et al.
Publicado: (1946)

Mumps: MMR vaccination and genetic diversity of mumps virus, 2007–2011 in Catalonia, Spain
por: Barrabeig, Irene, et al.
Publicado: (2019)

Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine
por: Fiebelkorn, Amy Parker, et al.
Publicado: (2014)

Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma
por: Khalid, Zumama, et al.
Publicado: (2023)

Inoculation against Mumps
Publicado: (1915)

Antiviral Activity of CD437 Against Mumps Virus
por: Kato, Fumihiro, et al.
Publicado: (2021)

1339 Measles and Mumps Antibody Response in Young Adults after a Third Dose of Measles-Mumps-Rubella Vaccine
por: Fiebelkorn, Amy Parker, et al.
Publicado: (2014)

Auto-immune thrombocytopenia after Measles Mumps Rubella MMR vaccination: molecular mimicry of measles virus phosphoprotein with platelet gpIIb
por: Tran, Guy Mong Ky, et al.
Publicado: (2010)

Mumps Complications and Effects of Mumps Vaccination, England and Wales, 2002–2006
por: Yung, Chee-Fu, et al.
Publicado: (2011)

Genetic heterogeneity of L-Zagreb mumps virus vaccine strain
por: Kosutic-Gulija, Tanja, et al.
Publicado: (2008)

Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine
por: Su, Shih-Bin, et al.
Publicado: (2020)

Characterization of Natural and Synthetic Sialoglycans Targeting the Hemagglutinin-Neuraminidase of Mumps Virus
por: Forgione, Rosa Ester, et al.
Publicado: (2021)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
por: Heijstek, MW, et al.
Publicado: (2008)

Response to Vaccination against Mumps in Medical Students: Two Doses Are Needed
por: Trevisan, Andrea, et al.
Publicado: (2021)

IMMUNITY IN MUMPS : IV. THE CORRELATION OF THE PRESENCE OF COMPLEMENT-FIXING ANTIBODY AND RESISTANCE TO MUMPS IN HUMAN BEINGS
por: Maris, Elizabeth P., et al.
Publicado: (1946)

Novel mumps virus epitopes reveal robust cytotoxic T cell responses after natural infection but not after vaccination
por: Kaaijk, Patricia, et al.
Publicado: (2021)

1076. Gaps in Measles and Mumps Seroprevalence Among Cancer Patients
por: Marquis, Sara, et al.
Publicado: (2020)

Measles-mumps-and-rubella-virus-vaccine: Aseptic meningitis: case report
Publicado: (2021)

Measles mumps and rubella virus vaccine: Various toxicities: case report
Publicado: (2022)

Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015
por: Cui, Aili, et al.
Publicado: (2017)

Mumps outbreak in university students: first detection of mumps virus genotype F in Borneo
por: Fong, Siat Yee, et al.
Publicado: (2022)

Genetic Analysis Reveals Differences in CD8(+) T Cell Epitope Regions That May Impact Cross-Reactivity of Vaccine-Induced T Cells against Wild-Type Mumps Viruses
por: Kaaijk, Patricia, et al.
Publicado: (2021)

Establishment of a standard seed lot system of an Iranian Mumps virus strain; RS-12, for mass production of mumps and MMR vaccines
por: Shahkarami, M K, et al.
Publicado: (2012)

IMMUNITY IN MUMPS : II. THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY AND DERMAL HYPERSENSITIVITY IN HUMAN BEINGS FOLLOWING MUMPS
por: Enders, John F., et al.
Publicado: (1945)

Naturally acquired anti-high mobility group box 1 antibodies during septic shock
por: Sauneuf, B, et al.
Publicado: (2009)

Serostatus of IgG antibody against mumps virus in adult population of Al Madinah Al Munawarah, Saudi Arabia
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

A HEMOLYSIN ASSOCIATED WITH THE MUMPS VIRUS
por: Morgan, Herbert R., et al.
Publicado: (1948)

Mumps Virus–associated Hemophagocytic Syndrome
por: Hiraiwa, Kunihiko, et al.
Publicado: (2005)

In vitro inhibition of mumps virus by retinoids
por: Soye, Kaitlin J, et al.
Publicado: (2013)

Protective effect of vaccination against mumps complications, Czech Republic, 2007–2012
por: Orlíková, Hana, et al.
Publicado: (2016)

Mumps
Publicado: (1908)

Mumps
Publicado: (1915)

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
por: Fusciello, Manlio, et al.
Publicado: (2022)

Naturally Acquired Antibodies against Plasmodium falciparum: Friend or Foe?
por: Tijani, Muyideen Kolapo, et al.
Publicado: (2021)

Consensus on the Development of Vaccines against Naturally Acquired Melioidosis
por: Limmathurotsakul, Direk, et al.
Publicado: (2015)

Measles–mumps–rubella vaccination and respiratory syncytial virus-associated hospital contact
por: Sørup, Signe, et al.
Publicado: (2015)

Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection
por: Mercader, Sara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tq47sfco2oj73j3n6dsfs1ict8